Journey Medical Corp Director's Stock Grant

On August 5, 2025, Neil Herskowitz, a director of Journey Medical Corp, was granted 20,000 restricted stock units under the company's 2015 Stock Plan, as amended. These units will vest in three equal installments on August 5, 2028, August 5, 2029, and August 5, 2030. Following this transaction, Herskowitz owns a total of 108,618 shares of common stock, including restricted stock units that vest over various periods. The transaction was reported in a Form 4 filing with the SEC on August 7, 2025.